The pharmaceutical degradation of Cyclin K by the molecular glue NCT02 also sensitized colorectal tumor spheroid culture cells, such as oxaliplatin and irinotecan, to chemotherapy [80]. The gene discussed is CCNK; the disease is colorectal neoplasm.